12-19-2013, 08:48 AM
thanks, but my question referred to this:
["an agreement to buy Given was accepted and signed. Since then several law firms are filing suit against the company and board for failure to execute their fiduciary responsibility of getting the best deal for shareholders. The deal price is $30/share. Given has been expecting FDA approval of their PillCam Colon product in the USA before year end. I was hoping that event would occur first before any buyout offer, as I was guessing such approval could boost the stock upwards of 20%."]
You seem to complain here (and people even start lawsuits) that they should have waited for FDA approval before selling the company.
My question was simply that a deal to buy the company, especially since approval was already given in other parts of the world (although how much that is as a guarantee that FDA would follow suit remains to be seen), how much value of FDA approval would be included in the take-over price?
If it's low, they should perhaps have waited for the FDA, one could even entertain the thought that since they didn't wait, perhaps they were not so sure the FDA would approve?
I might miss a lot here since I'm not familiar with the details of the story, but at least some shareholders seem upset enough to start lawsuits, apparently.
["an agreement to buy Given was accepted and signed. Since then several law firms are filing suit against the company and board for failure to execute their fiduciary responsibility of getting the best deal for shareholders. The deal price is $30/share. Given has been expecting FDA approval of their PillCam Colon product in the USA before year end. I was hoping that event would occur first before any buyout offer, as I was guessing such approval could boost the stock upwards of 20%."]
You seem to complain here (and people even start lawsuits) that they should have waited for FDA approval before selling the company.
My question was simply that a deal to buy the company, especially since approval was already given in other parts of the world (although how much that is as a guarantee that FDA would follow suit remains to be seen), how much value of FDA approval would be included in the take-over price?
If it's low, they should perhaps have waited for the FDA, one could even entertain the thought that since they didn't wait, perhaps they were not so sure the FDA would approve?
I might miss a lot here since I'm not familiar with the details of the story, but at least some shareholders seem upset enough to start lawsuits, apparently.